Licensed pertussis vaccines in the United States.

The United States switched from whole cell to acellular pertussis vaccines in the 1990s following global concerns with the safety of the whole cell vaccines. Despite high levels of acellular pertussis vaccine coverage, the United States and other countries are experiencing large pertussisoutbreaks. The aim of this article is to describe the historical context which led to acellular pertussis vaccine development, focusing on vaccines currently licensed in the US, and to review evidence that waning protection following licensed acellular pertussis vaccines have been significant factors in the widespread reappearance of pertussis.

 

Authors:Klein NP.

Journal:Hum Vaccin Immunother. 2014

Link:http://www.ncbi.nlm.nih.gov/pubmed/25483496